Contact
searchSearch
HMP Global
Login

July/August 2021

Feature

Research Reports
Treatment and Outcomes Among Hospitalized COVID-19 Patients With Immune-mediated Inflammatory Diseases: An Electronic Health Record Database Cohort Study
08/20/2021
Christopher D. Pericone, PhD; Kimberly Woodruff, PharmD, PhD; Emily S. Brouwer, MPH, PharmD, PhD; Alex Z. Fu, PhD; Qian Cai, MSPH, MS
Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.
Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.
Alex Z Fu, PhD, and colleagues...
08/20/2021
Journal of Clinical Pathways
From the Field
Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma
08/20/2021
Laura Alwan, PharmD; Evan Hall, MD; Kate Trieselmann, PharmD; Allison Kupsh, PharmD; Eve Segal, PharmD
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and...
08/20/2021
Journal of Clinical Pathways

Column

Editor's Page
Catching Up After Summer Break
08/20/2021
Winston Wong, PharmD
Winston Wong, PharmD, discusses the articles in this issue, which include research examining the impact of a SARS-CoV-2 infection on patients previously diagnosed with immune-mediated inflammatory diseases, and results from a study examining...
Winston Wong, PharmD, discusses the articles in this issue, which include research examining the impact of a SARS-CoV-2 infection on patients previously diagnosed with immune-mediated inflammatory diseases, and results from a study examining...
Winston Wong, PharmD, discusses...
08/20/2021
Journal of Clinical Pathways
COA Viewpoint
SCOTUS Upholds Limits on Pharmacy Benefits Managers
08/19/2021
Ricky Newton, CPA
Ricky Newton, CPA, weighs in on states seeking to enact legislation regulating pharmacy benefit managers, which he describes as the "next frontier" in the ongoing war with the pharmacy benefit managers.
Ricky Newton, CPA, weighs in on states seeking to enact legislation regulating pharmacy benefit managers, which he describes as the "next frontier" in the ongoing war with the pharmacy benefit managers.
Ricky Newton, CPA, weighs in on...
08/19/2021
Journal of Clinical Pathways
Clinical Pathways GPS
Clinical Pathways Improving Management of Rare Conditions
08/19/2021
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH,...
08/19/2021
Journal of Clinical Pathways
Pharma Insights
The Complementary Relationship Between Quantitative and Qualitative Research Methods in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment
08/19/2021
Marlon Graf, PhD; Rifat Tuly, MPH; Suepattra G. May, MPH, PhD
Marlon Graf, PhD, and colleagues discuss how evidence generated through a mix of both quantitative and qualitative research methods are necessary in addressing complexity in healthcare innovation and care delivery.
Marlon Graf, PhD, and colleagues discuss how evidence generated through a mix of both quantitative and qualitative research methods are necessary in addressing complexity in healthcare innovation and care delivery.
Marlon Graf, PhD, and colleagues...
08/19/2021
Journal of Clinical Pathways
Trending From ACCC
Geriatric Assessment is Critical for Treating Older Adults with Cancer
08/19/2021
The Association of Community Cancer Centers discuss how conducting a geriatric assessment can help uncover the comorbidities and age-related vulnerabilities that can impact cancer treatment in older adults.
The Association of Community Cancer Centers discuss how conducting a geriatric assessment can help uncover the comorbidities and age-related vulnerabilities that can impact cancer treatment in older adults.
The Association of Community...
08/19/2021
Journal of Clinical Pathways

Department

Clinical Pathways Forum
Internally Developed Clinical Pathways in an Integrated Health System
08/19/2021
Mishellene McKinney, MHA, RN, OCN
Mishellene McKinney, MHA, RN, OCN discusses how Kaiser Permanente's Excellence in Cancer Care program uses clinical pathways to take an enterprise approach to care while considering the unique capabilities and demographics and autonomy of...
Mishellene McKinney, MHA, RN, OCN discusses how Kaiser Permanente's Excellence in Cancer Care program uses clinical pathways to take an enterprise approach to care while considering the unique capabilities and demographics and autonomy of...
Mishellene McKinney, MHA, RN,...
08/19/2021
Journal of Clinical Pathways
JCP March/April 2025

Current Issue

April 2025
Volume 11
Issue 2
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

August 2021 Volume 7 Issue 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use